Acrivon Therapeutics, Inc. Common Stock Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ADAG
Adagene Inc. |
$2.05 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
AnaptysBio, Inc. |
$14.51 | $640.07 M | -3.82 | 117 | $17.16 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.00 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.27 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.53 | $597.48 M | -6.84 | 51 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$12.33 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.08 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
Opthea Limited |
$3.34 | $214.34 M | -1.04 | 33 | $124,666 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.50 | $85.40 M | -1.26 | 63 | $0 |
RZLT
Rezolute, Inc. |
$4.39 | $229.57 M | -5.02 | 59 | $0 |